603259 药明康德
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额3,595,81017,203,16212,406,51513,386,91210,616,030
投资活动产生之现金流量净额(5,348,369)(1,945,110)(5,518,177)(7,560,534)(9,690,286)
筹资活动产生之现金流量净额(74,979)1,123,541(3,832,191)(3,941,384)(1,277,808)
汇率变动对现金及现金等价物的影响(198,775)(370,473)387,525132,140160,633
现金及现金等价物净增加/(减少)(2,026,313)16,011,1193,443,6722,017,135(191,432)
期初现金及现金等价物余额29,455,83113,444,71110,001,0397,983,9048,175,336
期末现金及现金等价物余额27,429,51829,455,83113,444,71110,001,0397,983,904